PRH

0.0200.00%
CY

Ching Yit Tay

CEO & Executive Director

Dr. Ching Yit Tay, also known as Wilson, M.B.B.S. (Singapore), M.Med Anaes (Singapore), F.A.M.S. (Anaes), F.I.P.P. (WIP, USA), C.I.P.S. (WIP, USA) serves as Chief Executive Officer and Executive Director at Livingstone Health Holdings Limited since February 4, 2021. He was Chief Operating Officer of Livingstone Health Holdings Limited since December 2018 until December 2019. He specialises in anaesthesiology with clinical experience. Upon completing his fellowship programme, Dr. Tay was an associate consultant between 2011 to 2013, a consultant from 2013 and 2014 and a visiting consultant from 2014 to 2016 at the Pain Management Centre and Department of Anaesthesiology of SGH. In late 2014, he left for private practice, before subsequently setting up his own private practice in 2015. He has extensive experience in managing and treating various chronic pain conditions such as neck/back pain, headache, abdominal/pelvic pain and cancer pain and is experienced in performing ultrasound-guided chronic pain interventions using high frequency sound waves. He has published a number of articles in peer reviewed journals and is frequently invited to speak at local and overseas conferences on pain-related topics. Dr. Tay is Anaesthesiologist and Pain Management Physician at Apicare Pain Specialist Pte. Ltd. and Apicare Medical Pte. Ltd. since September 2015. Dr. Tay served as Visiting Consultant at Singapore General Hospital (Anaesthesia) since October 2014 until December 2016. Dr. Tay served as Consultant at Singapore Paincare Centre since October 2014 until August 2015. Dr. Tay served as Consultant (Anaesthesia) at Singapore General Hospital since May 2013 until September 2014. Dr. Tay served as Associate Consultant (Anaesthesia) at Singapore General Hospital since June 2011 until April 2013. Dr. Tay served as Registrar (Anaesthesia), Medical Officer and House Officer at Singapore Health Services Pte. Ltd. since May 2004 until May 2011. Dr. Tay has attended the requisite training (LED 1, LED 2, LED 3 and LED 4) conducted by the Singapore Institute of Directors. Dr. Tay has also attended a briefing conducted by the Legal Adviser on Singapore Law on the Proposed Transactions on the roles and responsibilities of a director and continuing listing and disclosure obligations. Dr. Tay is also actively involved in teaching and conducting hands-on chronic pain intervention workshops. He graduated from NUS in 2004 and was awarded Master of Medicine (Anaesthesiology) in 2009. After completing his specialist training, he pursued and completed a multi-disciplinary chronic pain clinical fellowship programme at St Joseph’s Health Care London in the city of London in Ontario, Canada in 2012. His present directorships include Apicare Medical pte. Ltd., Apicare Pain Specialist pte. Ltd., Livingstone Health Consolidated Pte. Ltd., Livingstone Endocrine Pte. Ltd., Cove Sports & Reconstruction Pte. Ltd., Livingstone Cardiology, Livingstone Endocrine, The Bone and Joint Centre Pte. Ltd., Phoenix Medical Group Pte. Ltd., Livingstone Cardiology Pte. Ltd., PMG and Other Companies includes LVS. His Past Directorships was DC Brothers Private Limited. Dr. Tay professional qualification include Registered Medical Specialist at Singapore Medical Council, Fellow at the Academy of Medicine, Singapore, Certified Interventional Pain Sonologist from World Institute of Pain, United States of America, Fellow of Interventional Pain Practice at World Institute of Pain, United States of America and Diploma in Acupuncture from Singapore College of Traditional Chinese Medicine. He graduated from the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery in 2004 and obtained his Master of Medicine (Anaesthesiology) in 2009. Following the completion of his specialist training in Singapore, he undertook a multidisciplinary chronic pain clinical fellowship at St. Joseph’s Health Care London in London, Ontario, Canada, in 2012.

Positions